Several factors that may contribute to this treatment dilemma include prehospital inaccuracy of the stroke diagnosis, inefficient in-hospital protocols, and lack of availability of efficient interhospital transportation, especially when IV-tPA therapy has been instituted. This evidence concerns the gene PLAT and Stroke.